Skip to main content

What Are the Problems?: Why Is It in the Economic Interest of OECD Countries to Address these Problems?

Buy Article:

$24.00 plus tax (Refund Policy)

This chapter outlines the impact of neglected infectious diseases in developing countries by citing current morbidity and mortality rates, elucidating the economic burden infectious diseases pose, highlighting the problems of lacking pharmaceutical products, explaining the drug research and development/innovation process, and discussing the economics of drug development. The chapter closes with a section on why OECD is interested in neglected and emerging infectious diseases that mainly affect developing countries.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Review Article

Publication date: 01 April 2009

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more